v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 2,749 $ 4,083 $ 5,740 $ 10,007
General and administrative 2,406 2,145 5,025 5,091
Total operating expenses 5,155 6,228 10,765 15,098
Loss from operations (5,155) (6,228) (10,765) (15,098)
Other income, net:        
Interest income 509 122 818 295
Other (expense) income, net (47) 367 (57) 410
Total other income, net 462 489 761 705
Net loss (4,693) (5,739) (10,004) (14,393)
Other comprehensive gain (loss), net:        
Unrealized loss on available-for-sale securities, net 0 0 0 (3)
Foreign currency translation gain (loss) 11 (346) 18 (393)
Total other comprehensive gain (loss), net 11 (346) 18 (396)
Comprehensive loss $ (4,682) $ (6,085) $ (9,986) $ (14,789)
Net loss per share, basic $ (0.04) $ (0.16) $ (0.10) $ (0.40)
Net loss per share, diluted $ (0.04) $ (0.16) $ (0.10) $ (0.40)
Weighted-average number of common shares outstanding, basic 111,805,635 35,719,317 104,085,316 35,653,455
Weighted-average number of common shares outstanding, diluted 111,805,635 35,719,317 104,085,316 35,653,455